ABIVAX announcements: ABX464 as HIV functional cure and novel treatment for inflammatory disease – Platforma

входит в структуру портала

Home
News EATG
ABIVAX announcements: ABX464 as HIV functional cure and novel treatment for inflammatory disease

EATG, EATG, News, News

ABIVAX announcements: ABX464 as HIV functional cure and novel treatment for inflammatory disease

December 10, 2016

ABIVAX reports new preclinical data supporting ABX464 as HIV functional cure and novel treatment for inflammatory diseases at HIV DART Meeting
ABIVAX provides update on clinical development program for ABX464 for functional cure of patients with HIV-infection

Original Article

Post Views: 1,178

Only 49% transmission rate observed in kidney transplants from HCV-positive donors, but lower graft and survival overall

New York reports fewer HIV diagnoses in 2015: target to reduce new infections by 75% by 2020

Related News

Behavioral intervention reduces HIV transmission risk in young transgender women

Behavioral intervention reduces HIV transmission risk in young transgender women

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe

Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe

Patient Communities Agree on Shared Vision of HIV Treatment Regimen

Patient Communities Agree on Shared Vision of HIV Treatment Regimen

Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection

Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection